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ABSTRACT
Neuregulin ligands and their ErbB receptors are important for the
development of Schwann cells, the glial cells of the peripheral
nervous system (PNS). ErbB3 deficiency is characterized by a
complete loss of Schwann cells along axons of the peripheral nerves,
impaired fasciculation and neuronal cell death. We performed
comparative gene expression analysis of dorsal root ganglia (DRG)
explant cultures from ErbB3-deficient and wild-type mice in order to
identify genes that are involved in Schwann cell development and
migration. The extracellular matrix (ECM) gene periostin was found to
exhibit the most prominent down regulation in ErbB3-deficient DRG.
Expression analysis revealed that the periostin-expressing cell
population in the PNS corresponds to Schwann cell precursors and
Schwann cells, and is particularly high in migratory Schwann cells.
Furthermore, stimulation of Schwann cells with neuregulin-1 (NRG1)
or transforming growth factor β (TGFβ-1) resulted in an upregulation of
periostin expression. Interestingly, DRG explant cultures of periostin-
deficient mice revealed a significant reduction of the number of
migrating Schwann cells. These data demonstrate that the
expression of periostin is stimulated by ErbB ligand NRG1 and
influences the migration of Schwann cell precursors.
KEY WORDS: Periostin, Schwann cells, Migration, Neuregulin,
Dorsal root ganglia, ECM
INTRODUCTION
Schwann cell precursors and PNS sensory neurons originate from
the neural crest. The neural crest cells that are fated to participate in
the formation of dorsal root ganglia (DRG) migrate through the
rostral half of each somite and condense in repetitive units on both
sides of the spinal cord. These nascent sensory ganglia comprise
neural and glial progenitors with heterogeneous developmental
potentialities. Upon differentiation of sensory neurons and axonal
outgrowth, Schwann cell precursors migrate from the DRG along
these projections. Later in development they differentiate into
myelinating or non-myelinating Schwann cells that envelope
sensory- and motor-neuron axons. The development of peripheral
nerve tissue results from a series of coordinated interactions
between neurons and Schwann cells (Jessen and Mirsky, 2005).
Targeted mutagenesis of different components of the ErbB-
signalling complex has demonstrated its importance for Schwann
cell development (Britsch et al., 1998; Garratt et al., 2000;
Michailov et al., 2004; Riethmacher et al., 1997; Taveggia et al.,
2005). Those experiments revealed that, later in development,
mutant embryos exhibit a total loss of Schwann cells along their
peripheral axons, whereas pre-migratory Schwann cells are present
near to the dorsal root ganglia but fail to migrate along the axons.
The impaired glial cell migration in these mutants indicates a direct
function in migration. This interpretation is supported by the finding
that mutations in the neuregulin–ErbB signalling system lead to
changes in neural crest migration in mice (Britsch et al., 1998) and
in directed Schwann cell migration in zebrafish (Lyons et al., 2005).
However, an earlier function in fate specification and/or
proliferation that could in turn be a prerequisite for migration
cannot be completely ruled out.
To identify components that are potentially involved in the
migration process of Schwann cells, we took advantage of the
impairment of Schwann cell migration in ErbB3-deficient embryos.
We conducted gene expression profiling of cultured embryonic
DRG [12.5 days post coitum (dpc)], isolated from wild-type and
ErbB3-deficient embryos. Aiming to identify genes expressed by
migrating Schwann cells, we have been focusing on genes that are
upregulated in wild-type compared with mutant cultures, because
the wild-type cultures are enriched for migrating Schwann cell
precursors as opposed to those that are immobile. Periostin was one
such gene that showed a higher expression in wild-type compared
with ErbB3-deficient cultures.
Periostin was originally isolated from osteoblasts and found to be
preferentially expressed in the periosteum, hence the name
(Horiuchi et al., 1999; Takeshita et al., 1993). Periostin contains
an N-terminal secretory signal peptide, followed by a cysteine-rich
domain, four internal homologous repeats and a C-terminal
hydrophilic domain. The four internal repeats region, the fasciclin
domains (Fas), exhibit homology to the axon guidance protein
Fasciclin I that is involved in the development of nervous system in
invertebrates (Zinn et al., 1988). Interestingly, in invertebrates, it is
expressed in neurons and attached to the membrane through a
glycosylphosphatidylinositol (GPI) anchor (Elkins et al., 1990),
whereas in vertebrates, it is a secreted protein with a much broader
expression pattern – including heart, periodontal ligament,
fibroblasts and Schwann cells. In primary osteoblasts, periostin
expression can be increased through stimulation with TGFβ-1
(Horiuchi et al., 1999). Several studies aiming to locate the protein
product have revealed its presence in the ECM surrounding the
expressing cells. In the ECM, periostin seems to be able to interact
with several other ECM molecules, including collagen and
tenascin-C (Kii et al., 2006, 2010). Furthermore, it has been
demonstrated that periostin promotes adhesion and potentiates
cancer cell motility by binding to integrins ανβ3 and ανβ5 (Gillan
et al., 2002), and that forced expression of periostin induces invasive
activity through epithelial–mesenchymal transition (EMT) in HEK-
293 cells (Yan and Shao, 2006). Several studies correlate periostin
expression with tumour angiogenesis and metastasis in humanReceived 8 May 2015; Accepted 25 June 2015
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cancer (Bao et al., 2004; Li et al., 2007; Malanchi et al., 2011;
Puglisi et al., 2008; Sasaki et al., 2001a,b, 2003). Additionally, high
pre-operative serum levels of periostin correlate with a poor
prognosis in individuals with hepatocellular carcinoma after
hepatectomy (Lv et al., 2013). Based on these observations, it has
been suggested that periostin belongs to the group of matricellular
proteins that are characterised as being modulators of cell-matrix
interactions and cellular function (Kii et al., 2010; Norris et al.,
2008). Interestingly, the existence of a non-secreted intracellular
pool of periostin that is able to suppress the invasiveness of cancer
cells, possibly by interacting with intracellular signalling molecules
such as TAB1 and Tak1, has also been described (Isono et al., 2009;
Yoshioka et al., 2002). In our current study, we show that periostin
expression is downregulated in ErbB3-deficient DRG. In cultured
rat Schwann cells, expression of periostin can be induced by
neuregulin-1 (NRG1) and TGFβ-1. Additionally, we demonstrate
that periostin deficiency leads to reduced migration of embryonic
Schwann cell precursors and that recombinant periostin is able to
promote cellular motility.
RESULTS
Genes expressed in migrating Schwann cell precursors
In order to identify genes that are potentially involved in Schwann
cell precursor migration, we performed DNAmicroarray expression
analysis with DRG explant cultures of ErbB3-deficient embryos. In
mutant cultures, the migration of Schwann cell precursors along the
axons did not occur, yet axonal outgrowth and neuronal survival in
these cultures was not impaired (Fig. 1A). At 12.5 dpc, the DRG of
ErbB3-deficient and wild-type embryos were isolated. Following
36 h of in vitro culture, the explant cultures were harvested, RNA
was isolated and then used to hybridize Affymetrix MicroArray
(probe sets MG-U74Av2, MG-U74Bv2 and MG-U74Cv2). After
evaluation of the obtained data sets, 176 genes were found to exhibit
a significantly higher expression in samples that had been derived
from wild-type DRG cultures, in contrast, only nine genes showed
increased expression in samples from ErbB3-deficient DRG. To
further analyse the data, we grouped the differentially expressed
genes into functional categories. The three major groups were
transcription-related proteins, ECM proteins and nuclear proteins
(Fig. 1B). However, when we focused our analysis on genes that
exhibited the most significant increases in expression in wild-type
DRG (top 20 of the list), 36% (7 out of 20) could be assigned to the
group of the ECM proteins (Fig. 1C).
The most prominent differential expression was detected for the
ECMmolecule periostin. To verify and further support this finding,
we next compared expression levels by using other approaches.
A virtual northern blot analysis employing the total RNA of DRG
explant cultures derived from wild-type and ErbB3-deficient
cultures confirmed the lower expression levels of periostin in
ErbB3-deficient cultures (Fig. 1D). Moreover, quantitative real-time
PCR (qRT-PCR) analysis revealed a 10.5-fold higher expression of
periostin in samples derived from wild type compared with those
from mutant cultures (data not shown). As the most prominent
difference between wild-type and ErbB3-deficient DRG cultures is
the population of migrating Schwann cell precursors, these results
point towards expression in these cells and also suggest a potential
role of periostin for the migration process of these cells.
Periostin expression in Schwann cells
We therefore analysed the expression pattern of periostin during
embryonic development by using in situ hybridisation of wild-type
embryos at different stages. Prominent periostin expression is
detectable in a variety of tissues and organs including bone,
cartilage, heart and tongue as early as 10.5 dpc. At this stage of
development, neural crest cells have already migrated out of the
neural tube, and DRG formation has been initiated. Periostin
expression was readily detectable in DRG at this early stage
(Fig. 2A), and expression within DRG persists throughout
embryonic development (Fig. 2B,C). At 12.5 dpc, strong
expression of periostin could additionally be detected along
axonal projections (Fig. 2D). To further characterise the
expression pattern, we made use of a mouse mutant in which the
β-galactosidase open reading frame had been fused in frame to the
ATG start codon of the periostin gene, thereby replacing most of
exon 1 and exon 2, resulting in a frameshift (the generation of these
mice will be described elsewhere). Heterozygous animals were
phenotypically normal but expressed the β-galactosidase gene
within the cells that expressed periostin. Co-immunofluorescence
Fig. 1. Microarray analysis of DRG explant
cultures of wild-type and ErbB3-deficient mice.
(A) DRG explant cultures of wild-type (+/+) and
ErbB3-deficient mice (−/−) were isolated from
embryos at 12 dpc, cultured for 72 h and imaged
under a microscope using phase contrast. Note
the absence of migrating Schwann cells in the
DRG culture from ErbB3−/− animals. Scale bar:
50 µm. (B) All genes with a higher level of
expression in wild-type DRG were grouped into
functional categories. (C) Twenty genes with the
highest differential expression were grouped into
classes. Note the high percentage of ECM
molecules (7 out of 20, 35%). (D) Virtual northern
blot of mRNA isolated from DRG explant cultures
of wild-type (+/+) and ErbB3-deficient mice (−/−).
The periostin-specific transcript was detected
through hybridisation with a radioactively labelled
periostin-specific probe. GAPDH was detected
accordingly and was employed as a loading
control.
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analysis of heterozygous embryos at 12.5 dpc with antibodies
specific for β-galactosidase and Sox10, a marker for glial cells
in the PNS, confirmed the expression of periostin in the glial
cell population (Fig. 3A–C). To examine the expression pattern
of periostin in DRG explant cultures, we performed a co-
immunofluorescence analysis that employed antibodies against
Sox10 and periostin. Sox10-positive cells were found to exhibit
robust periostin expression (Fig. 3D–F). Interestingly, even though
the majority of the protein is secreted and can be detected in and
purified from the supernatant, periostin was also detected within
the cells.
Different isoforms of periostin varying within the 3′-translated
region have been described (Horiuchi et al., 1999; Litvin et al.,
2004). Interestingly, exon 17 has not been included in the official
periostin cDNA or protein sequences; however, it is present in the
genome sequence releases and thus should be included. Exon 17 has
been described by Litvin et al. as only being present in the isoform
periostin-like factor (PLF) (Litvin et al., 2004), whereas Kyutoku
et al. correctly state it to be part of the periostin coding region
(Kyutoku et al., 2011). To assess the presence of different periostin
isoforms in glial cells of the PNS, we generated cDNA from DRG.
Amplification by using gene-specific primers and subsequent
sequence analysis revealed the expression of five different
isoforms in embryonic glial cells, one of which (isoform IV) was
previously unidentified (Fig. 4). Wewere able to detect a full-length
transcript (containing all 23 exons) and several variants where either
exon 21 (isoform II) or 17 (isoform III) were absent, or a
combination of exons 17 and 20 (isoform IV) or exon 17, 20 and
21 (isoform V) were absent (Fig. 4).
Relocalisation of periostin through neuregulin-1 and
stimulation of periostin transcription in Schwann cells
As we identified periostin in our screen as being upregulated in
wild-type DRGs compared with ErbB3-deficient DRGs, we next
investigated whether the neuregulin–ErbB signalling system has
any direct influence on periostin expression levels. For these
experiments, we used the S16 Schwann cell line, which closely
corresponds to Schwann cells at an early stage of myelination (Toda
et al., 1994). These cells express the ErbB receptors and are
responsive to NRG1 (data not shown). S16 cells were grown either
on laminin or on poly-DL-ornithine (PDO), and left unstimulated or
were stimulated with NRG1. In cells grown on PDO, non-secreted
periostin localized in the centre of the cytoplasm, surrounding the
nucleus (Fig. 5A), whereas in cells grown on laminin, periostin was
observed mainly at the protrusions of the cells (Fig. 5C).
Interestingly, upon stimulation with NRG1, expression levels
appeared to be upregulated and the protein localized at cellular
protrusions, whether cells were grown onPDOor laminin (Fig. 5B,D).
Thus, the stimulation with NRG1 of S16 Schwann cells that had
been grown on PDO resulted in a relocalisation of periostin,
reminiscent of the localisation of the protein that was observed when
cells were grown on a migration-promoting surface such as laminin.
To assess the impact of NRG1 stimulation on periostin expression
levels, we performed a qRT-PCR analysis. S16 cells were cultured
until they were semi-confluent and then stimulated with NRG1,
TGFβ-1 or a mixture of both factors. TGFβ-1 is a known stimulator
Fig. 2. Expression analysis of periostin in DRG. (A–D) Periostin expression
during development was followed by using in situ hybridisation with a
35S-labelled periostin-specific probe on sagittal sections of wild-type embryos
at different stages. Expression in several connective tissues, the periosteum
and the valves of the heart has been previously described. Also note the strong
expression in the umbilical cord, highlighted with an asterisk (A,B).
(A) Expression at 10.5 dpc. Note the expression in the DRG, indicated by
arrows. (C) Expression at 16.5 dpc shows that the robust expression within the
DRG persists (arrows). (B,D) Expression at 12.5 dpc. D is a higher
magnification of the boxed area in B. Note the higher expression along axonal
projections (arrowheads) compared with the expression level within the DRG
(arrows). Scale bars: 250 µm (A); 500 µm (B,C); 125 µm (D).
Fig. 3. Co-expression of periostin and Sox10 in DRG and DRG explant
cultures. (A–C) Periostin expression in DRG was analysed by using
immunohistochemistry analysis of sagittal sections of heterozygous periostin-
mutant embryos at 12.5 dpc. (A) To identify cells that expressed periostin, we
made use of the β-galactosidase (green) expression, which reflects the
periostin expression in heterozygous periostin mutants. Note that the
β-galactosidase remained within the expressing cells in contrast to periostin,
which was secreted. (B) Glial cells were identified through expression of the
glial marker Sox10 (red). (C) An overlay of the images in A and B is shown.
Note the strong expression of periostin (β-galactosidase) in the area of the
nerve root (arrows). (D–F) Periostin expression in DRG explant cultures was
assessed by co-immunostaining with antibodies against periostin (green, D)
and Sox10 (red, E). An area several millimetres away from the ganglia, where
mostly migrating Sox10-positive Schwann cells are located, is shown. (F) An
overlay of the images in D and E is shown. Note the substantial overlap of
Sox10 and periostin expression in migrating Schwann cells. Scales bars:
100 µm (A–C); 10 µm (D–F).
3347
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 3345-3355 doi:10.1242/jcs.174177
Jo
ur
na
lo
f
Ce
ll
Sc
ie
nc
e
of periostin expression in a variety of cell types (Horiuchi et al.,
1999; Tai et al., 2005). Stimulation with NRG1 resulted in an almost
fivefold increase of periostin expression, whereas stimulation with
TGFβ-1 resulted in a sixfold increase compared with that of
unstimulated cells (Fig. 5E). Interestingly, we observed an 11-fold
increase of periostin transcription levels upon combined stimulation
with both NRG1 and TGFβ-1 (Fig. 5E), suggesting that the ErbB3
ligand NRG1 and TGFβ-1 cooperate to upregulate periostin
expression in S16 Schwann cells.
Periostin interacts with laminin and a variety of ECM
molecules
Periostin is known to interact with collagen I (Norris et al., 2007), as
well as other ECM molecules such as fibronectin, tenascin-C and
collagen IV (Kii et al., 2010; Takayama et al., 2006). The
relocalisation of periostin in S16 Schwann cells that had been
cultured on laminin prompted us to investigate whether periostin
and laminin can interact directly. In order to test such a potential
interaction, a His10- and c-Myc double-tagged recombinant
periostin construct (isoform I, full length) was expressed in HEK-
293 cells and purified to homogeneity from cellular supernatants by
using Ni2+-affinity chromatography, as assessed by using SDS-
PAGE and western blotting (Fig. 6A). Solid-phase binding assays
demonstrated a robust interaction of recombinant periostin with
laminin and a less pronounced interaction with collagen I and
fibronectin (Fig. 6B). This interaction was dependent on the
presence of Ca2+ because without added Ca2+, no specific
interaction could be detected (data not shown). We were unable to
observe any specific interaction with collagen IV (Fig. 6B). To
further corroborate this interaction between periostin and laminin,
we performed co-immunoprecipitation experiments with periostin-
expressing cells and exogenously added laminin. In these
experiments we were able to co-precipitate periostin by using
laminin-specific antibodies (Fig. 6C). Having demonstrated the
potential of the two proteins to physically interact, we determined
their location in developing nerves. Wewere able to co-localise both
proteins in developing nerves by employing sections of DRG and
spinal nerves from 12.5-dpc embryos (Fig. 7A). Co-localization and
the ability to physically interact indicate that there is a functional
interplay between the two molecules in vivo.
Periostin stimulates migration of Schwann cell precursors
and HEK-293 cells
Because we discovered periostin in an expression analysis that aimed
to identify genes which are potentially involved in Schwann cell
migration, we next examined the effect of periostin expression on
Schwanncellmigration.To this end,weusedembryonicDRGcultures
from periostin-deficient and wild-type mice and compared Schwann
cell migration. Several groups, including ours, have independently
generated periostin-deficient animals (Kii et al., 2006;Oka et al., 2007;
Rios et al., 2005) (A. Brodarac, Impaired tooth development in
periostin deficient mice, PhD thesis, University of Hamburg, 2006).
These mice do not show any overt phenotype during embryonic
development, and thegross development of thePNSappears normal in
the absence of periostin expression. Interestingly, when we analysed
DRG cultures, we observed severely reduced migration of Sox10-
positive Schwann cells in periostin-deficient cultures compared with
that in wild-type cultures, whereas the axon outgrowth was not
impaired (Fig. 7B). To characterise this in more detail, we monitored
migration in several independent cultures from wild type, and
heterozygous and homozygous periostin mutants. Schwann cell
migration in cultures fromheterozygousmutantswas normal, whereas
Fig. 4. Periostin isoforms in wild-type DRG
explant cultures. (A) Nucleotide sequence of the
C-terminal domain of murine periostin. Exons 16 to
23 (up to the stop codon) are shown. The exons are
boxed and alternate between white (even) and
grey (odd). The exon lengths (number of
nucleotides) are indicated in brackets. Note that
excision of any exon from exon 17 to exon 22 does
not induce a frameshift. (B) Isoforms identified in
wild-type DRG explant cultures are shown,
depicting exon composition, length and calculated
molecular mass. For this analysis, mRNA of DRG
explant cultures that had been cultured for 3 days
was isolated, then cDNA was generated and
amplified with specific primer sets F15 (forward
primer exon 15) and R23 (reverse primer exon 23),
subcloned and sequenced. In all variants, exons
16, 18, 19, 22 and 23 were present. Note that
variant IV has not been described before.
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in cultures from periostin-deficient embryos, we observed a 50%
reduction inmigration (Fig. 8A).Attempts to rescuemutant cultures by
either prior coating of the dishes with periostin or by adding it to the
medium were not successful (data not shown). We next analysed
whether periostin deficiency has any impact on Schwann cell
proliferation or apoptosis in these cultures as this would also affect
the outcome of our migration analysis. However, proliferation and
apoptosis rates in wild-type and periostin-deficient DRG cultures
showed no significant differences (Fig. 8B). The finding that neither
proliferation nor apoptosis were affected in these cultures clearly
suggests that periostin has a direct impact on themigratory capacity of
Schwann cell precursors.
Because periostin has been implicated in migration processes in a
variety of cell types and different contexts (i.e. cancer, cutaneous
wound healing), we wanted to support our observations of DRG
cultures by employing another experimental setup. Therefore,
periostin- or mock-transfected HEK-293 cells were analysed in a
Boyden chamber assay using conditionedmedium from these cells or
control medium that did not contain any periostin (Fig. 8C). In this
experimental setup, conditioned medium containing periostin
strongly stimulated the migration of HEK-293 cells. Interestingly,
migrationwas highest when cellswere exposed to periostin but did not
express it endogenously (Fig. 8D), and the observed migration in this
experimental setupwas regarded as 100%.Periostin-expressingHEK-
293 cells exhibited a slightly lower migration rate (80%). When no
periostin was present in the medium, mock-transfected (EGFP)
control cells were stationary, whereas periostin-expressing cells were
still able to migrate (40%) (Fig. 8D). To assess whether this higher
migration rate was accompanied by higher rates of proliferation of
Fig. 5. Expression analysis of periostin in S16 Schwann cells.
(A–D) Periostin expression in S16 cells was analysed by using
immunocytochemistry with a periostin-specific antibody (red). Nuclei were
visualized by Hoechst 33342 staining. S16 cells were plated on poly-DL-
ornithine (PDO)- (A,B) or laminin-coated (C,D) dishes, cultured with serum-
free medium and then treated with 10 ng/ml NRG1 (Nrg) for 4 h (B,D) or the
treatment with NRG1 was omitted (unstimulated) (A,C). Note the relocalisation
of periostin upon NRG1 stimulation on PDO (B). Expression of periostin
appears to be upregulated upon stimulation with NRG1 on both substrates.
Scale bar: 10 µm (A–D). (E) To analyse the upregulation in more detail, S16
cells were plated on laminin-coated dishes, cultured with serum-free medium
and stimulated for 24 h with 10 ng/ml NRG1 (Nrg) or 1 ng/ml TGFβ-1 (TGFβ), a
known stimulator of periostin expression in a variety of cell types. Periostin
transcript levels were analysed by using qRT-PCR for three independent
experiments. A strong and significant increase in periostin expression could be
observed after stimulation with NRG1, TGFβ-1 or stimulation with both
(Nrg/TGFβ) compared with that of unstimulated cells (unstim.). Significance is
indicated as *P<0.05, **P<0.01, ***P<0.001.
Fig. 6. Interaction of periostin with ECM molecules. (A) Periostin
comprising a C-terminal His-tag and an additional c-Myc epitope was
expressed in HEK-293 cells and purified by using Ni2+ affinity chromatography.
Coomassie-stained SDS-PAGE and immunoblotting using a Myc-specific
antibody revealed a protein with a molecular mass in the expected range of
slightly above 90 kDa. (B) Interaction of periostin with ECM molecules was
analysed by using a solid-phase assay. 100 µg/ml of the ECMmolecules were
coated onto 96-well plates and incubated with 50 µg/ml recombinant periostin
in the presence of Ca2+ in the binding buffer. Interaction of periostin was
detected using an anti-c-Myc HRP conjugate and visualized using ABTS as a
substrate. Note that the interaction was Ca2+-dependent as binding in the
absence of Ca2+ was below the control level and did not vary between the
different ECM molecules. Significance is indicated as **P<0.01, ***P<0.001.
FN, fibronectin; Lam, laminin; Col, collagen (isoforms IV and I, respectively).
(C) Co-immunoprecipitation of laminin (Lam.) and periostin (Per.) was
performed in mock (−) or periostin (+) transfected HEK-293 cells. Laminin (+)
was added to the supernatant and complexes were precipitated using a
laminin-specific antibody. The interaction was assessed by immunoblotting
and detection of precipitated periostin with aMyc-specific antibody. The control
lanes (c) represent the input before immunoprecipitation, whereas the ‘IP’
lanes show the results after immunoprecipitation.
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these cells, which might influence the migration behaviour, a BrdU
labelling experiment was performed. Again, wewere unable to detect
any changes in the proliferation rates (data not shown). These findings
and the results obtained using DRG cultures clearly indicate that
periostin can increase the migratory capacity of cells.
DISCUSSION
Considerable progress has been made in the identification of
molecules involved in neural crest cell development and in
understanding their impact on processes – including proliferation,
differentiation and de-differentiation (Crane and Trainor, 2006;
Dupin et al., 2007). However, there is only scarce knowledge of the
molecules involved in Schwann cell migration. One important
player in neural crest and Schwann cell development is the
neuregulin–ErbB signalling system (Newbern and Birchmeier,
2010). DRG explant cultures of ErbB3-deficient embryos reflect the
migration impairment of the Schwann cell precursor (Riethmacher
et al., 1997) and therefore represent an ideal model for expression
analyses of the genes that are involved in migration when compared
with those of wild-type cultures. Our microarray analyses revealed a
prominent differential expression of ECM molecules, which is
independently supported by microarray data that has been collected
using isolated neural crest stem cells and Schwann cell precursors
(Buchstaller et al., 2004). The highly differential expression of ECM
molecules coincides with axonal growth and the on-going process of
Schwann cell precursor migration along the axons, suggesting a
potential involvement of such ECM components in these processes.
Furthermore, ECM molecules and their receptors have been
implicated in Schwann cell development and function (Chernousov
et al., 2008), as well as migration (Chernousov et al., 2001; Milner
et al., 1997). The ECM protein periostin, which exhibited the most
significant differential expression in our microarray analysis,
is expressed in a variety of tissues during development, including
DRG and Schwann cell precursors, as shown by us and others
(Kruzynska-Frejtag et al., 2001; Lindsley et al., 2005).
So far, several isoforms of periostin with varying domain
compositions in the C-terminus, generated through alternative
splicing, have been reported (Horiuchi et al., 1999; Litvin et al.,
2004; Ozdemir et al., 2014). Using RNA that was isolated from
DRG cultures, we could identify five different isoforms, including
an isoform that has not been described previously. The exact
function and physiological relevance of the different isoforms
remain elusive. However, because periostin has been implicated in a
variety of different, partially even conflicting, functions (Bao et al.,
2004; Kim et al., 2005; Shao et al., 2004), alternative splicing might
offer an explanation for these findings. Similarly, the different
isoforms present in the precursor and migrating Schwann cells might
have varying impacts on cellular behaviour – e.g. motility. Further
experiments are required to investigate how different compositions of
the C-terminus influence the ability to interact with other ECM
molecules or receptors. In this context, it will also be interesting to
determine the expression levels of the different splice variants.
In order to identify the biological functions of periostin, several
labs have independently generated periostin-deficient mice.
Surprisingly, despite the robust expression during embryonic
development, mutants show apparently normal development and
are viable, indicating that there is a backup mechanism for periostin
function in its absence. The most apparent phenotype is impairment
of the eruption of incisors, which first presents itself shortly after
weaning (A. Brodarac, Impaired tooth development in periostin
deficientmice, PhD thesis, University ofHamburg, 2006) and causes
secondary defects such as malnutrition and dwarfism (Kii et al.,
2006; Rios et al., 2005). More recent studies involving different
challenging strategies have revealed subtle defects in skin, tendons,
heart valves, and changes in regeneration dynamics following
myocardial infarction (Norris et al., 2008, 2007; Oka et al., 2007;
Shimazaki and Kudo, 2008; Snider et al., 2008). Interestingly, subtle
phenotypes during normal development and impairment of tissue
remodelling and repair are hallmarks of mice carrying targeted
mutations in other matricellular proteins (Bornstein and Sage, 2002).
Although Schwann cell development is normal in periostin-
deficient animals, in this paper we were able to show that cultured
DRG of periostin-deficient animals could not sustain Schwann cell
migration at levels comparable to those of wild-type DRG. During
development, there is most likely to be an alternative mechanism
operating in the absence of periostin that is not present in our DRG
culture. This experimental setup shows that periostin can be involved
in cell migration. Our Boyden chamber assay further showed that the
concentration and localisation of periostin is also important for its
migratory function.We therefore conclude that periostin can influence
the migratory behaviour of Schwann cells and also other cells, but in
the absence of periostin, other proteins – i.e. murine TGFBI – can
Fig. 7. Colocalisation and influence on migration. (A) Immunostaining of
cryosections from a 12.5-dpc embryo showing the area of the thoracic DRG
with periostin- (green) and laminin-specific (red) antibodies. Note the
substantial overlap of the expression domains, both within the DRG and along
the axonal projection. (B) Immunostaining of DRG explant cultures derived
from wild-type and periostin-deficient embryos (12.5 dpc) using the
Neurofilament200 (Nf200, green) antibody and an antibody specific for Sox10
(red). Axonal projections (lengths and numbers) are comparable between
genotypes, whereas the number of migrating Schwann cell precursors (Sox10
positive) is clearly reduced in periostin-deficient cultures. Nf200/Sox10, co-
staining of neurofilaments and Sox10. Scale bars: 100 µm (A,B).
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compensate for its function during embryonic development.
Interestingly, our preliminary data indicate that the absence of
periostin leads to delayed and reduced regeneration after peripheral
nerve injury (E.S.-R. and D.R., unpublished data). We show here that
paracrine expression alone enhances migration compared with
simultaneous paracrine and autocrine expression (Fig. 8D).
However, if no paracrine expression is present, cells expressing
periostin in an autocrine fashion are more likely to migrate than cells
that lack periostin. The migratory function is also interesting with
respect to expression of periostin in tumour development and
metastasis. The ability of tumour cells to migrate and invade other
tissues is an important prerequisite for the development of metastasis
(Hanahan and Weinberg, 2000). Papers with conflicting results have
been published showing that upregulation as well as downregulation
of periostin can lead to a more severe tumour phenotype and to
enhanced metastasis (Kim et al., 2005; Malanchi et al., 2011; Morra
and Moch, 2011). This leads us to propose a model in which the
periostin expression levels of the tumour itself, the periostin expression
levels of the surrounding tissue and the periostin levels in the serum
cooperatively influence the metastatic potential of a tumour.
We showed that the expression levels of periostin are not only
influenced by TGFβ-1, as previously shown (Horiuchi et al., 1999),
but also by NRG1. Additionally, the interaction of the two ligands
results in a higher expression level than either ligand on its own
(Fig. 5E). Experiments using different conditions have shown that
the neuregulin signalling and TGFβ-1 can cooperate to influence the
invasiveness of cancer cells (He et al., 2011), and also in peripheral
nerve regeneration (Ribeiro-Resende et al., 2009). Both of these
studies suggest the existence of cooperative, synergistic effects for
Fig. 8. Influence of periostin on migration. (A) DRG explant cultures from
periostin deficient (−/−), heterozygous (+/−) or wild-type (+/+) embryos
(12.5 dpc) were cultured for 72 h and stained with an antibody against Sox10
(red) to visualise the Schwann cells (see Fig. 7B). The Sox10-positive
migrating cells per DRG were counted in all DRG that had adhered to the
coverslip and divided by the number of DRG. The mean number of wild-type
cultures was taken as 100% migration and compared with the mean numbers
of heterozygous and periostin-deficient cultures. Wild-type and heterozygous
cultures showed very similar values, whereas a significant difference
(***P<0.001) became apparent in periostin-deficient cultures. (B) Proliferation
and apoptosis. Proliferation was followed by treatment of the DRG explant
cultures with BrdU for 1 h. Apoptosis was monitored by applying the TUNEL
method. Schwann cells were visualized by using a Sox10-specific antibody.
The cells positive for both BrdU and Sox10, or TUNEL and Sox10 were
counted and related to the total number of Sox10-postitive cells. No significant
differences could be detected. (C) Boyden chamber assay. Conditioned
medium from HEK-293 cells that either stably expressed periostin
(CM+Periostin) or did not express periostin (CM−Periostin) was added to the
lower well of a chemotactic chamber. Either periostin (Hek-Periostin) or mock
transfected (Hek-EGFP) HEK-293 cells were plated at equivalent densities on
the membrane of the upper chamber. After 48 h, the membrane was stained
and the cells counted. (D) Several independent assays were performed and
statistically analysed. All observed differences were highly significant
(***P<0.001, not indicated in graph for clarity). The highest migration activity
was observed in experiments when mock-transfected cells were assayed in
the presence of periostin in the conditioned medium (white box). These values
were taken as 100% and compared with the other values. Interestingly, cells
expressing periostin that had been assayed in the presence of periostin in the
conditionedmedium (light grey) just reach 80% (*P<0.05), suggesting that very
high levels of periostin might impede migration. Note that cells expressing
periostin are able to migrate in this assay, even when no periostin was added in
the conditioned medium (dark grey), whereas no migration was detected when
non-expressing cells were assayed in the absence of periostin in the medium
(black).
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TGFβ-1 and neuregulin signalling. From our results, it is very
possible that these effects are mediated through periostin. In recent
experiments, it has been shown that Wnt5a can also upregulate
periostin expression but seems to exert this upregulation solely
through augmentation of TGFβ-1 levels (Hasegawa et al., 2015).
The connection between neuregulins and the expression level of
periostin, as well as our preliminary data on nerve regeneration, are
exciting as a recent paper shows that re-expression of neuregulins
after injury to Schwann cells is highly important for regeneration
and remyelination (Stassart et al., 2013).
Our results show that periostin exists in a variety of isoforms and
that its expression levels are influenced cooperatively by different
ligands of receptor kinases. Furthermore, periostin can interact with
different ECM molecules, and these interactions are most likely to
affect the localisation of periostin. Therefore, this study suggests
that periostin is a protein that is involved in cell motility, the exact
function of which can be fine-tuned through expression levels,
interaction partners and also possibly different isoforms.
MATERIALS AND METHODS
Transgenic mice
Generation, maintenance and genotyping of mice heterozygous for a
deletion in ErbB3 has been described previously (Riethmacher et al.,
1997), whereas generation and genotyping of periostin-deficient mice
will be described elsewhere (A. Brodarac, Impaired tooth development in
periostin deficient mice, PhD thesis, University of Hamburg, 2006). All
animals in Hamburg were cared for according to the ‘Guide for the Care
and Use of Laboratory Animals’ prepared by the National Academy of
Sciences and published by the National Institutes of Health (NIH;
publication 86-23 revised 1985), and experiments involving animals bred
in Southampton were performed under a Home Office Licence and in
accordance with the Animals (Scientific Procedures) Act, 1986, UK.
DRG cultures
Heterozygous mutant animals were mated, and pregnant females euthanized
at 12.5 dpc. The embryonic DRG were dissected and grown in a defined
medium that has been used previously for embryonic mouse neurons
(Davies, 1998). Genotyping was performed using standard techniques
with the following primers – ErbB3 forward-1 5′-GGGTGTCTGAGTC-
TTTGAAGCTGGAG-3′, reverse-1 5′-ACCTGTAATCTCCCGACTGT-
CCTGAA-3′, reverse-2 5′-CGAATTCGCCAATGACAAGACGCTGG-
3′; Periostin forward-1 5′-TGTGGTGGCAGAGACAGAAG-3′, reverse-1
5′-CTCCCCTGTGGTGCATTTAC-3′, reverse-2 5′-GTTGCACCACAG-
ATGAAACG-3′.
Cell culture
S16 cells were maintained in Dulbecco’s modified Eagle’s medium that had
been supplemented with heat-inactivated 10% fetal calf serum. All cell
culture reagents were purchased from Invitrogen unless otherwise specified.
TGFβ-1 from porcine platelets as well as collagen I, collagen IV, collagen V
and fibronectin were purchased from Sigma. NRG1 was purchased from
Neomarkers, and Laminin-1 from Roche Applied Science. The anti-
periostin antibody was an affinity purified polyclonal antibody from rabbit
directed against the first 347 amino acids of the protein without the leader
sequence. The monoclonal Sox10 antibody was provided by Michael
Wegner (University of Erlangen, Germany).
Isoform analysis
DRG explant cultures were cultivated for 36 h, and total RNA was extracted
using Trizol (Invitrogen). Reverse transcription was performed with
Superscript II (Invitrogen) and oligo(dT) primer. Transcribed cDNA
was amplified using periostin-specific primers F15 and R23 (forward
primer 5′-CATCCACGTCGTGGACAAACTCCTC-3′, reverse primer 5′-T-
TGGCTTCTGTTGGTTGTCA-3′) and purified by using agarose gel
electrophoresis. The amplicons were isolated and then subcloned into
pGemT easy vectors (Promega); the constructs were subsequently sequenced.
Microarray hybridisation
DRG explant cultures were cultivated for 36 h, and total RNA was
isolated using Trizol (Invitrogen), according to the manufacturer’s
instructions. RNA was reverse transcribed using a T7-promoter-tagged
polyT primer [5′-GGCCAGTGAATTGTAATACGACTCACTATAGGGA-
GGCGG-(dT)24-3′], and antisense RNA was produced using T7 RNA
polymerase. Antisense RNA was examined by using gel electrophoresis.
Equivalent amounts of RNA from five age-matched embryos of the same
genotype were pooled to generate a microarray probe. Probes were biotin-
labelled in a second round of T7 amplification, as previously described (Luo
et al., 1999). Profiles of ErbB3-deficient micewere comparedwith the profiles
of wild-type littermates of the same genetic background. Microarray profiling
was performed in triplicate from independent preparations of embryonic RNA
using Affymetrix MG-U74Av2, MG-U74Bv2 and MG-U74Cv2 GeneChips
(36,000 sequences). Data were normalized, and comparative analyses were
performed using the statistical algorithm of Affymetrix Microarray Suite
(MAS) 5.0 software following the manufacturer’s guidelines. Ranking and
filtering of genes was performed using Microsoft Excel.
Virtual northern blot
Total RNA from DRG cultures was transcribed with oligo-dT primer by
reverse transcriptase and amplified using the SMART™ technology
(Clontech) following the manufacturer’s guidelines. Thereafter, Southern
blots were performed using the first 582 nucleotides of the periostin cDNA
or full-length GAPDH labelled with [32P]-CTP.
In situ hybridisation and immunohistochemistry
Embryos were isolated at 10–16.5 dpc from staged pregnancies and fixed in
4% paraformaldehyde (PFA; in PBS) for 4–16 h. Samples were then
equilibrated in 30% sucrose, embedded in OCT (Miles), frozen and
sectioned using a cryostat. In situ hybridisation was performed as described
previously (Sonnenberg et al., 1991). The first 582 nucleotides of periostin
were used as periostin-specific probe.
For immunohistochemistry, embryos and tissues were fixed in 4% PFA in
PBS at 4°C overnight, cryoprotected in 20% sucrose in PBS for 12 h at 4°C,
embedded in OCT compound (Miles) and sectioned using a cryostat
(thickness of 10 μm). Sections were rinsed three times with PBS, blocked for
30 min with PBS containing 0.1% Triton X-100 and 0.2% bovine serum
albumin (BSA) and incubated overnight with primary antibodies at 4°C. After
being washed three times with PBS (each wash lasting 5 min), the sections
were incubatedwith the appropriate secondary antibodies conjugated toAlexa
466 (Molecular Probes) or Cy3 (Jackson Laboratories; Chemicon) for 1 h and
then washed. Primary mouse immunoglobulin G1 antibodies were detected
with Zenon technology (Molecular Probes). After the sections had been
rinsed with PBS and nuclei had been counterstained with 4′,6′-diamidino-2-
phenylindole (DAPI; 0.001 mg/ml of PBS), sections were examined with a
Zeiss Axioplan 2 microscope, and images were taken with a Zeiss AxioCam
digital camera (Brockschnieder et al., 2004). In the case of double-labelling
experiments, slides were fixed in 4% PFA (in PBS) for 30 min after the final
wash. Then the second primary antibody was added, and the procedure
described above was followed through again. The following antibodies were
used in this study: anti-Sox10 (monoclonal antibody fromMichael Wegner’s
Lab); anti-periostin (Abcam); anti-β-galactosidase (Cappel); anti-laminin
(Lab Vision Corporation).
Expression of recombinant proteins
Total RNA from DRG cultures was transcribed with oligo-dT primer 5′-
GACCACGCGTATCGATGTCGAC-(dT)16-3′ by reverse transcriptase.
Periostin cDNA was amplified by using gene specific primers 5′-GGCT-
GAAGATGGTTCCTCTC-3′ and a primer binding to the overhang of
the oligo-dT primer (5′-GACCAGGCGTATCGATGTCGAC-3′). For
recombinant protein expression, the cDNA was amplified with primers 5′-
GATCGCTAGCATGGTTCCTCTCCTG-3′ and 5′-GATCGCGGCCGC-
CTGAGAACGGCCTTC-3′ providing NheI and NotI restriction sites,
respectively. The PCR product was purified by using agarose gel
electrophoresis and inserted into pcDNA5/FRT (Invitrogen) providing a
10×His and a c-Myc tag at the 3′-end. In order to generate stable lines, Flp-In
HEK-293 cells (Invitrogen) were transfected with the expression vector
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using jet PEI (Q BIO gene) following the manufacturer’s guidelines. This
cell line enables the rapid generation of stable expression from a defined
locus. The protein was purified from the supernatant by using immobilized
metal ion affinity chromatography using Ni-NTA-matrix (Qiagen)
following the manufacturer’s guidelines and was then dialyzed against PBS.
Quantitative real-time PCR
Total RNA for qRT-PCR analyses was extracted from S16 cells that had
been cultured for 24 h on laminin-coated plates in Opti-Mem medium and
subsequently stimulated with 10 ng/ml NRG1 or 1 ng/ml TGFβ-1 for 24 h.
After treatment with RNase-free DNase for 30 min at 37°C to remove
genomic DNA, the quantity and quality of the RNA was determined by
using the RNA 6000 Nano LabChip Kit (Agilent). The cDNA was
synthesised from 3 µg of total RNA using 1 µg random primers with
Superscript II (Invitrogen) and spiked with the amylose extender1 (ae I)
gene from wheat. qRT-PCR was performed using the ABI PRISM 7700
(ABI). The efficiency of cDNA synthesis was evaluated by amplifying the
ae I cDNA (ae I forward 5′-ACGCGATGCCCTCCATAG-3′, ae I reverse
5′-AATTCGAGACCGGATCCT-3′). All reactions contained 15 ng cDNA,
300 nM periostin forward primer 5′-TTCCGAGAGATCATCCAACC-3′,
50 nM periostin reverse primer 5′-AGGCTGAGGAAGATGCTGAA-3′
(product size 82 bp), 18S 60 nM forward primer 5′-CGGCTACCACATCC-
AAGAA-3′, 18S 60 nM reverse primer 5′-GCTGGAATTACCGCGGCT-3′
(product size 182 bp) and QPCR Mastermix for SYBR® Green I
(Eurogentec) in a final volume of 20 µl. Primer concentrations and
conditions were optimised in preliminary experiments. The thermal profile
started with an initial step of 50°C for 2 min, followed by 10 min 95°C to
activate the polymerase and subsequently 40 cycles each comprising 15 s
95°C and 1 min 65°C. In each analysis, all samples were run in parallel.
The control gene selected to normalize each sample for RNA content was
18S ribosomal RNA. The fold difference was analysed by using the
standard deviation calculations using the relative standard curve method.
The paired sample t-test was used to evaluate the significance of differences
in expression in paired groups.
Western blot analysis and immunoprecipitation
Cells were washed twice with ice-cold PBS and lysed with a buffer
containing 50 mM Tris-HCl (pH 7.4), 150 NaCl, 1% Nonidet P-40, 1 mM
phenylmethylsulfonyl fluoride and a protease inhibitor cocktail (Complete
mini, Roche). Protein extracts or purified protein were separated by using
SDS-PAGE, transferred to PVDF membrane (Millipore), blocked with 5%
milk powder in PBS and incubated with the indicated antibodies overnight.
Immunoreactive bands were visualized by using chemiluminescence
(Millipore). For immunoprecipitation, the HEK-293 cells were transfected
with a plasmid expressing periostin or β-galactosidase. Laminin was added
to the cell culture medium and, at 24 h after transfection, the supernatant was
collected and precleared with protein-G/A–Sepharose (Santa Cruz
Biotechnology) for 2 h at 4°C. The pre-cleared supernatant was incubated
with anti-laminin antibody (1:100) (Clone A5, NeoMarkers) overnight. The
immunocomplex was extensively washed, the samples (30 µg) were
subjected to immunoblotting, and periostin was detected with anti-c-Myc
antibody (clone 9E10, Sigma).
Solid-phase assay
96-well plates (Nunc) were coated overnight with 100 µg/ml of collagen I,
collagen IV, collagen V, fibronectin, bovine serum albumin fraction V
(Sigma) and laminin (Roche). After blocking with 5% milk powder in
100 mM Tris-HCl pH 7.5, 150 mM NaCl, 200 ng/ml of recombinantly
expressed and purified periostin was incubated for 5 h in 100 mM Tris-HCl
pH 7.5, 150 mM NaCl or 100 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM
CaCl2. Periostin was detected using an anti-c-Myc horseradish peroxidase
(HRP) conjugate. The immunoreactivity was visualized by using ABTS as a
substrate and measured at 405 nm.
Migration analysis
For the migration assay, HEK-293 cells were transfected for 36 h with
plasmid encoding periostin or β-galactosidase. The conditioned medium
was collected and filtered. Additionally, HEK-293 cells were transfected for
24 h with plasmids encoding periostin or EGFP. 1×105 of these cells were
then transferred onto 8-µm pore polycarbonate filter (Nunc). The lower
chamber of Transwell inserts was loaded with the conditioned medium.
After 24 h of incubation, the top cells on the Transwell membrane were
removed using Q-tips. The cells trapped by the membrane were fixed and
stained with Diff-Quick (Düdingen, Switzerland). Cell numbers within the
entire membrane area were determined.
For the analyses of Schwann cell migration, DRG explant cultures were
cultured for 72 h and were then analysed by immunofluorescence using an
antibody against Sox10 and the Neurofilament 200 antibody (Sigma) to
visualise Schwann cells and axons, respectively. All migrating Sox10-
positive cells per DRG were counted.
BrdU incorporation in cultured DRG
The DRG explant cultures were cultured for 48 h and incubated for 1 h with
10 µM BrdU, washed with PBS and fixed for 20 min with Carnoy’s fixative
(methanol and acetic acid, 3:1) at −20°C. Subsequently, the DRG cultures
were incubated for 15 min with 2.4 MHCl at 37°C. To identify incorporated
BrdU, thus proliferating cells, an antibody against BrdU (Roche) was used.
TUNEL staining
The DRGwere cultured for 48 h and fixed with 1% PFA (in PBS) for 10 min
at room temperature. To identify apoptotic cells, the ApopTag Apoptosis
detection kit (Q-BIOgene) was used following the manufacturer’s
guidelines.
Statistical analysis
In all experiments, appropriate statistical analysis (ANOVA, t-test) was
performed using GraphPad Prism 4 or MiniTab (Release 15) software. Data
are shown as mean values with standard errors of the mean.
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